DMK PHARMACEUTICALS CORPORATION Increase (Decrease) in Other Receivables
DMK PHARMACEUTICALS CORPORATION reported Increase (Decrease) in Other Receivables of $30.95 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2023-11-14
- DMK PHARMACEUTICALS CORPORATION increase (decrease) in other receivables for the quarter ending 2022-12-31 was $950.36K.
- DMK PHARMACEUTICALS CORPORATION increase (decrease) in other receivables for the quarter ending 2022-09-30 was $278.42K.
- DMK PHARMACEUTICALS CORPORATION increase (decrease) in other receivables for the quarter ending 2022-06-30 was -$757.83K.
- DMK PHARMACEUTICALS CORPORATION increase (decrease) in other receivables for the quarter ending 2022-03-31 was -$440.00K.
- DMK PHARMACEUTICALS CORPORATION increase (decrease) in other receivables for fiscal 2022 was $30.95K, a 99.52% decline from fiscal 2021.
- DMK PHARMACEUTICALS CORPORATION increase (decrease) in other receivables for fiscal 2021 was $6.49M.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2022-12-31 | $950.36K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $1.23M derived: sum of 2 quarters · filed 2023-11-14 | $470.95K derived: sum of 3 quarters · filed 2023-11-14 | $30.95K 10-K · filed 2023-03-16 |
| 2022-09-30 | $278.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$479.41K derived: sum of 2 quarters · filed 2023-11-14 | -$919.41K 10-Q · filed 2023-11-14 | -$919.41K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$757.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | -$1.20M 10-Q · filed 2023-08-21 | -$1.20M derived: sum of 3 quarters · filed 2023-08-21 | |
| 2022-03-31 | -$440.00K 10-Q · filed 2023-05-15 | -$440.00K derived: sum of 2 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $6.49M 10-K · filed 2023-03-16 | ||
| 2021-09-30 | $6.49M 10-Q · filed 2022-11-14 |